A protein isolate used in formula manufactured by HiPP-Werk Georg Hipp OHG has been deemed “a nutritionally safe and suitable protein source for use in infant and follow-on formula” by EFSA.
The European Food and Safety Authority (EFSA) has rejected claims a peptide blend included in infant formula could reduce the risk of developing atopic dermatitis.
With its first purchase order from Nestlé-owned Garden of Life in hand, Norwegian biotech company Hofseth BioCare (HBC) is gearing up for significant growth in North America with new products, exciting science, and unique claims.